Log In or Register to Join The Conversation!

BVS857 Improves Muscle Volume in Patients with SMA

This topic has 0 replies, 1 voice, and was last updated 2 years, 6 months ago by SMA News Today Moderator.

  • Author
    • #15258

      Novartis Pharmaceuticals‘ investigational compound BVS857 significantly improved muscle volume in patients with X-linked type spinal muscular atrophy (SMA) over a short period of time, Phase 2 clinical results show. However, the compound failed to improve muscle strength and function. Click here to read more.

      What do you think about this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?


Create Account

Copyright © 2017-2021 All rights reserved.